- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Endometriosis Ovary in Hong Kong
Total 25 results
-
The University of Hong KongPrincess Margaret Hospital, Canada; Kwong Wah Hospital; Pamela Youde Nethersole... and other collaboratorsRecruitingEndometriotic Cyst of OvaryHong Kong
-
Chinese University of Hong KongRecruitingEndometriosis | Endometriosis Ovary | Endometriosis-related PainHong Kong
-
Chinese University of Hong KongGuangdong Provincial Hospital of Traditional Chinese Medicine; Sun Yat-sen... and other collaboratorsCompleted
-
The University of Hong KongUnknown
-
Chinese University of Hong KongCompletedEndometriosis | AdenomyosisHong Kong
-
Chinese University of Hong KongRecruitingEndometriosis | AdenomyosisHong Kong
-
Chinese University of Hong KongRecruiting
-
The University of Hong KongKwong Wah Hospital; Pamela Youde Nethersole Eastern Hospital; The Queen Elizabeth... and other collaboratorsRecruitingPolycystic Ovary Syndrome | AnovulationHong Kong
-
The University of Hong KongUnknownPolycystic Ovarian Syndrome | SubfertilityHong Kong
-
Chinese University of Hong KongRecruitingPolycystic Ovarian Syndrome | Fertility Issues | Premature Ovarian Insufficiency | Anti-Müllerian HormoneHong Kong
-
Chinese University of Hong KongNot yet recruitingRecurrent MiscarriageHong Kong
-
Myovant Sciences GmbHCompletedEndometriosis Related PainUnited States, Spain, Hungary, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Poland, Portugal, South Africa, Ukraine
-
ObsEva SATerminatedEndometriosisUnited States, Canada, Puerto Rico
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedEndometriosis | Dysmenorrhea | Pelvic Pain | DyspareuniaHong Kong, United States, Canada, Australia, United Kingdom, South Africa, Belgium
-
AbbVieCompletedEndometriosisUnited States, Canada, Puerto Rico
-
Sumitomo Pharma Switzerland GmbHRecruitingEndometriosis | Uterine FibroidsUnited States
-
Sumitomo Pharma Switzerland GmbHActive, not recruiting
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Dedifferentiated Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Endometrial Adenocarcinoma | Recurrent Endometrial... and other conditionsUnited States, Korea, Republic of, Canada, Puerto Rico, Japan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Mucinous... and other conditionsUnited States, Korea, Republic of, Japan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous... and other conditionsUnited States, Korea, Republic of, Canada, Japan
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditionsUnited States, Korea, Republic of, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedMelanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditionsUnited States